Oncology Ventures

Profile

Oncology Ventures is a venture capital firm based in Austin, Texas, founded by Ben Freeberg. The firm consists of a team of dedicated professionals depending on their expertise to invest in startups that are transforming cancer care. The team includes industry veterans and an advisory board with experienced members from top healthcare institutions like The Parker Institute and The Oncology Institute. What sets Oncology Ventures apart is their specific focus on commercially-validated technologies to optimize cancer treatment, particularly through data-driven approaches.

The firm invests in healthcare data companies that tackle significant issues in the oncology sector. Their focus areas include early detection, precision diagnostics, care navigation, and AI-powered treatment optimization. Oncology Ventures supports startups at various stages, expected primarily in North America, and has $62 million in assets under management, dedicated through their Cancer Care Fund II.

Notable investments by Oncology Ventures include Risa, which enhances operational efficiency in cancer centers; IgniteData, which streamlines research coordination; Tono, aiding patients in managing treatment side effects; Concr, with an AI platform that improves survival rates; and other innovative healthcare startups. These investments showcase the firm's commitment to pioneering advancements in cancer care by leveraging technology and data.